Korean medtech firms skipped the hype and showed their hand at this year’s Korea International Medical & Hospital Equipment Show (KIMES 2025), spotlighting AI tools built for waiting rooms, not research labs. 

InBody pulls clinical malnutrition screening out of hospitals


Nearly 50 attendees line up to try InBody’s GLIM-based malnutrition screening kiosk for muscle and frailty assessment. (Credit: Korea Biomedical Review)
At InBody’s booth, nearly 50 attendees queued up to try the company’s malnutrition screening kiosk—a Global Leadership Initiative on Malnutrition (GLIM)-aligned system that measures skeletal muscle index, fat-free mass, and grip strength in under two minutes. 

Best known for its body composition analyzers, InBody is now pushing into clinical nutrition with a tool aimed at catching frailty in elderly and cancer patients.

At the booth, an InBody spokesperson said the company is targeting “places people actually pass through”—government buildings, corporate offices, and pharmacies—not just hospitals. “We’re pulling this out of clinical settings and into daily life,” she said. 

No paper forms were in sight and only tablets were used at the booth. "The results now sync directly to a tablet or app, eliminating paper and appointment bottlenecks."

A gait analysis module, still in development, will add mobility loss as a data point—another key factor in GLIM-based evaluations. The first launch markets are aimed for Korea and Japan, where national guidelines have already begun incorporating GLIM criteria into public health screening.

출처 : KBR(https://www.koreabiomed.com)